Turkey Tail (PSK/PSP)
Mushroom extract: β-Glucan/DC/NK ↑; strong adjunct OS in gastric/colorectal/breast/lung.
Forms: PSK extract capsules (1 g, 3x/day) · PSP powder (standardized polysaccharide)
Key Takeaway
PSK/PSP polysaccharides from Trametes versicolor activate innate/adaptive immunity (DCs, NK/CTL) and have improved survival signals in GI cancers as an adjunct to 5-FU–based therapy.
Evidence at a glance
30+ trials/meta; OS HR 0.75 in gastric (Oba meta); NK ↑30% in pilots; ongoing breast/NSCLC; PDQ-endorsed.
How it may work
β-Glucans engage Dectin-1/CR3 → Syk/NF-κB, maturing DCs and promoting Th1 cytokines (IL-12/IFN-γ). This enhances NK and CD8⁺ cytotoxicity and supports antigen presentation. Clinical trials/meta-analyses in gastric/colorectal cancers report OS benefits with PSK adjunct to chemotherapy.
Targets & pathways
Curated mechanistic targets reported for this agent — how it may act on cells, not proof of a clinical effect.
- β-Glucan PRR↑Dectin-1/CR3 activation for immune priming
- Dendritic↑Maturation and antigen presentation
- NK↑Cytotoxicity enhancement
- Th1 Cytokines↑IL-12/IFN-γ production
- CTL↑CD8⁺ T-cell support
Often studied / combined with
Combinations reported in the literature, not a protocol or a recommendation.
- 5-FU: Prolonged OS in gastric/colorectal meta-analyses.
- Curcumin: DC maturation boost in lung models.
- Resveratrol: NK co-enhancement in breast cancer.
- Quercetin: Th1 amplification in prostate models.
Overlapping mechanisms
- β-Glucan PRR: Overlaps maitake/lentinan; select by standardization.
- NK ↑: Redundant with reishi; monitor lymphocyte counts.
Safety & interactions
Severity and how well-established each signal is are shown separately. Verify everything with your oncologist or pharmacist — absence here does not mean safe.
- immunotherapiesMonitorModerateTheoreticalCytokine overlap; potential enhancement.
- chemotherapySynergizeLowTheoreticalImmune support with 5-FU.
- 5-FUSynergizeLowTheoreticalOS benefit in gastric/colorectal.
Timing
- With-meal: Improves tolerance.
- TID: Divided for steady priming.
References
- PMC10183216: PSK/PSP in GI cancer meta-analysis
- mushrooms-pdq: NCI PDQ on medicinal mushrooms
- S0753332223002123: Immune mechanisms of PSK
- turkey-tail-mushroom: Clinical overview and safety
- DOI 10.3390/nu12061619: Synergy with 5-FU in gastric models
- PMC10221542: Combination with curcumin in lung cancer
Research
No published studies for Turkey Tail (PSK/PSP) yet
New studies appear here once they’ve been reviewed. Browse all studies.
Dose: as studied, not a recommendation
Ranges seen in adjunct / practice use: 1–3 g/day (po) divided TID; with meals, Adjunct 3 g/day PSK; trials use 1 g TID; monitor immune markers; long-term safe..
Trials studying Turkey Tail (PSK/PSP)
No actively-recruiting trials matched right now. Recruiting is not the same as proven. Search ClinicalTrials.gov →